lithium carbonate + lithium citrate

Lithium carbonate + lithium citrate is a combination pharmaceutical product composed of two lithium salts that both deliver the active moiety lithium, a mood-stabilizing small molecule used primarily in bipolar disorder and, in some settings, for acute mania and maintenance therapy. After administration, both salts dissociate to provide lithium ions, which modulate intracellular signaling pathways including inhibition of inositol monophosphatase and glycogen synthase kinase 3, altering neurotransmission, second-messenger signaling, and neuronal plasticity. The combination is best understood as a lithium-containing formulation rather than a mechanistically distinct new agent, and its clinical effects, therapeutic monitoring requirements, and toxicity profile are expected to align with other oral lithium products, including risks of tremor, renal impairment, thyroid dysfunction, and narrow therapeutic index requiring serum lithium monitoring.

Other names

lithium carbonate + lithium citrate